By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – MDxHealth today said that it has renewed and amended an existing licensing agreement with Veridex for use of certain DNA methylation biomarkers for colorectal cancer and prostate cancer screening.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.